Come up with a name for your new list and we'll add to it:
Agendia raised a round of funding on July 25, 2018. Investors include
Athyrium Capital Management.
Agendia is a privately held, leading molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decision…